- Home
- GEVO vs RCKT Comparison
GEVO vs RCKT Comparison
Compare GEVO & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEVO
- RCKT
- Stock Information
- Founded
- GEVO 2005
- RCKT 1999
- Country
- GEVO United States
- RCKT United States
- Employees
- GEVO N/A
- RCKT N/A
- Industry
- GEVO Major Chemicals
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- GEVO Industrials
- RCKT Health Care
- Exchange
- GEVO Nasdaq
- RCKT Nasdaq
- Market Cap
- GEVO 418.4M
- RCKT 328.6M
- IPO Year
- GEVO 2011
- RCKT N/A
- Fundamental
- Price
- GEVO $1.73
- RCKT $3.28
- Analyst Decision
- GEVO Buy
- RCKT Buy
- Analyst Count
- GEVO 2
- RCKT 13
- Target Price
- GEVO $7.58
- RCKT $12.96
- AVG Volume (30 Days)
- GEVO 9.4M
- RCKT 6.0M
- Earning Date
- GEVO 08-11-2025
- RCKT 08-07-2025
- Dividend Yield
- GEVO N/A
- RCKT N/A
- EPS Growth
- GEVO N/A
- RCKT N/A
- EPS
- GEVO N/A
- RCKT N/A
- Revenue
- GEVO $80,187,000.00
- RCKT N/A
- Revenue This Year
- GEVO $909.99
- RCKT N/A
- Revenue Next Year
- GEVO $22.37
- RCKT $108.43
- P/E Ratio
- GEVO N/A
- RCKT N/A
- Revenue Growth
- GEVO 341.75
- RCKT N/A
- 52 Week Low
- GEVO $0.67
- RCKT $2.19
- 52 Week High
- GEVO $3.39
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- GEVO 57.77
- RCKT 51.17
- Support Level
- GEVO $1.54
- RCKT $2.88
- Resistance Level
- GEVO $1.86
- RCKT $3.74
- Average True Range (ATR)
- GEVO 0.14
- RCKT 0.27
- MACD
- GEVO 0.01
- RCKT 0.02
- Stochastic Oscillator
- GEVO 31.15
- RCKT 35.43
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.